MedTrace Logo

A Trial of Levator Muscle Blocks Following Posterior Colporrhaphy Surgery to Reduce Post-operative Pain.

NCT03067168 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2019-01-07

No results posted yet for this study

Summary

To determine if levator muscle block with bupivacaine improves postoperative pain control relative to placebo controls among women undergoing prolapse surgery involving a posterior colporrhaphy. Improvement is defined as no less than a 25% lower total pain score on a ten point numerical pain scale.

Conditions

  • Post Operative Pain

Interventions

DRUG

Bupivacaine

5 mL of 0.5% bupivacaine will be injected into 2 locations bilaterally.

DRUG

normal saline 0.9%

5 mL of 0.9% normal saline will be injected into 2 locations bilaterally.

Sponsors & Collaborators

  • University of Kansas Medical Center

    collaborator OTHER

  • The Christ Hospital

    lead OTHER

Principal Investigators

  • Carson T Kaeser, MD · The Christ Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-15
Primary Completion
2019-06-01
Completion
2019-08-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03067168 on ClinicalTrials.gov